Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000215780

Medchemexpress LLC Buloxibutid (AT2 receptor agonist C21) | 477775-14-7 | MFCD26936332 | 96.8% | 475.62 | C23H29N3O4S2 | 50 MG
SDP

Catalog No. 5000215780
Encompass_Preferred

Buloxibutid is a selective angiotensin II type 2 (AT2) receptor agonist (C21) used in research to study AT2-mediated GPCR signaling and related biological effects. It exhibits high affinity for AT2 and minimal activity at AT1, with manufacturer-provided data for solubility and storage to support experimental use.

  • Selective AT2 receptor agonist with Ki 0.4 nM
  • Markedly lower affinity for AT1 receptor (>10 μM)
  • Soluble in DMSO at 50 mg/mL for in vitro applications
  • In vivo formulation guidance provided with multiple solvent sequences tested
  • Powder stable at -20°C for long-term storage; solution storage limits specified

Catalog No. 50-002-15780 Supplier Medchemexpress LLC Supplier No. HY10011350MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Buloxibutid is a selective angiotensin II type 2 (AT2) receptor agonist (C21) used in research to study AT2-mediated GPCR signaling and related biological effects. It exhibits high affinity for AT2 and minimal activity at AT1, with manufacturer-provided data for solubility and storage to support experimental use.

  • Selective AT2 receptor agonist with Ki 0.4 nM
  • Markedly lower affinity for AT1 receptor (>10 μM)
  • Soluble in DMSO at 50 mg/mL for in vitro applications
  • In vivo formulation guidance provided with multiple solvent sequences tested
  • Powder stable at -20°C for long-term storage; solution storage limits specified

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.